How effective is imported Pembrolizumab?

Pembrolizumab has shown remarkable results in the treatment of cancer, whether imported or otherwise. It is an immune checkpoint inhibitor that enhances the body's immune system's ability to attack cancer cells by blocking the interaction between PD-1 and PD-L1. Pembrolizumab has been widely used in patients with non-small cell lung cancer (NSCLC). In some clinical trials, the drug has shown promising results in the treatment of advanced and metastatic NSCLC, particularly in those patients who are PD-L1 positive.

Pembrolizumab has also shown good results in the treatment of melanoma, prolonging patient survival and improving treatment response rates. Pembrolizumab is widely used in the treatment of metastatic renal cell carcinoma, where it can improve patient survival and achieve partial or complete tumor shrinkage in some cases. Pembrolizumab has shown some efficacy in the treatment of recurrent or metastatic head and neck squamous cell carcinoma, especially in patients with high levels of PD-L1 expression.

PembrolizumabThe original drug is already on the market in China. SpecificationsThe price per box of 100mg/4ml may be around RMB 15,000. This drug is a strictly controlled drug and has not yet been included in medical insurance. Pembrolizumab The price of the European version of the original drug 100mg/4ml per box may be around RMB 25,000, and the price of the Turkish version of 100mg/4ml per box may be around 10,000 RMB (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same, and they are expensive. There are currently no generic versions of Pembrolizumab available overseas.